Changes of activin A and activin binding protein in patients with cerebrovascular disease before and after treatment

Xue-ling Cui,Bo-song Qing,Yu Yang,Qing Yang,Ying Chang,Zhong-hui Liu
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.02.046
2006-01-01
Abstract:AIM: To observe the changes of activin A, activin binding protein and cellular immune function in patients with cerebrovascular disease before and after treatment, and compared with healthy people. METHODS: The experiment was performed in the Staff Room of Immunology, Jilin University from 2004 to 2005. Levels of activin A in serum of subjects in the normal control group (n=20), cerebral hemorrhage group (n=20) and cerebral infarction group (n=20) before and after treatment were assayed with radioimmunoassay (RIA), levels of activin binding protein in serum of subjects in three groups before and after treatment were detected by enzyme linked immunosorbent assay (ELISA), and T lymphocyte proliferation activities were detected with lymphocyte blastogenesis test.RESULTS: ①Level of activin A in serum: It was significantly higher in the cerebral hemorrhage group and cerebral infarction group before treatment than that in the normal control group (P < 0.01), and decreased obviously after treatment. Compared with normal control group, there was not significant difference (P < 0.05). ②Level of activin binding protein in serum: It was significantly higher in the cerebral hemorrhage group before treatment than that in the normal control group (P < 0.01), and decreased obviously. Compared with normal control group, there were no significant differences (P < 0.05); It was a little higher in the cerebral infarction group before treatment than that in the normal control group (P < 0.01), and increased after treatment; Compared with the normal control group, there were no significant differences (P < 0.05); There were no obvious differences between the cerebral infarction group before treatment and normal control group (P < 0.05). CONCLUSION: ① Levels of activin A and activin binding protein in serum of patients with cerebral hemorrhage increased significantly, which is near normal after treatment; Level of activin A in serum of patients with cerebral infarction increased obviously, which is near normal after treatment. ② The decreasing of T lymphocyte transforming activity in patients with cerebral hemorrhage may relate to the increasing of activin A in immunosuppressive activity.
What problem does this paper attempt to address?